To evaluate the feasibility and efficacy of a specific aortomonoiliac endograft and the durability of the femorofemoral bypass for treatment of abdominal aortic aneurysm (AAA).
Methods:
From 2002 to 2004, 39 high-risk (ASA III/IV) patients (36 men; median age 74 years, range 63–84) with AAA (n=33) or AAA and common iliac artery aneurysm (n=6) were treated with an EndoFit aortomonoiliac endograft and femorofemoral crossover bypass. The contralateral iliac axis was obstructed with an endoluminal occluder. Patients were followed with contrast-enhanced computed tomography at 1, 6, 12, and 24 months.
Results:
EndoFit AMI stent-grafts were implanted successfully in all patients. Perioperative mortality was zero. Endoleak occurred in 3 (7.7%) cases. A proximal type I endoleak was identified at 1 month and was treated with a proximal cuff. Two type II endoleaks are under surveillance because the aneurysm sac shows no enlargement. Thrombosis of the femorofemoral graft occurred in 1 case during the immediate postoperative period due to insufficient inflow from a residual stenosis of the endograft (primary patency 97.5%). The deficit was treated successfully (secondary patency 100%). Two (5.1%) tunnel hematomas were treated conventionally. Median follow-up was 14 months (range 6–30). All patients are alive. None of the aneurysms has ruptured or been converted to an open procedure. Graft migration, serious infection, paraplegia, distal embolization, or any other serious complication has not been observed.
Conclusions:
In high surgical risk patients with complex iliac anatomy, aortomonoiliac endograft with femorofemoral crossover bypass is feasible and efficacious. Moreover, the midterm patency of the extra-anatomic bypass appears quite satisfactory.
GreenhalghRMBrownLCKwongGP. Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative mortality results: Randomised controlled trial. Lancet. 2004; 364: 843–848.
2.
PrinssenMVerhoevenELGButhJ. A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms. N Engl J Med.2004; 351: 1607–1618.
CarpenterJPBaumRABarkerCF. Durability of benefits of endovascular versus conventional abdominal aortic aneurysm repair. J Vasc Surg.2002; 35: 222–228.
5.
FariesPLBrenerBJConnellyTL. A multicenter experience with the Talent endovascular graft for the treatment of abdominal aortic aneurysms. J Vasc Surg.2002; 35: 1123–1128.
6.
LeeAWCarterJWUpchurchG. Perioperative outcomes after open and endovascular repair of intact abdominal aortic aneurysms in the United States during 2001. J Vasc Surg.2004; 39: 491–496.
7.
BrewsterDCCronenwettJLHallettJW. Guidelines for the treatment of abdominal aortic aneurysms. Report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery. J Vasc Surg.2003; 37: 1106–1117.
8.
RutherfordRBKrupskiWC. Current status of open versus endovascular stent-graft repair of abdominal aortic aneurysm. J Vasc Surg.2004; 39: 1129–1139.
9.
AbuRahmaAFStonePABatesMC. Endovascular repair of abdominal aortic aneurysms using 3 commercially available devices: Midterm results. J Endovasc Ther.2004; 11: 641–648.
10.
MooreWSKashyapVSVesceraCL. Abdominal aortic aneurysm: A 6-year comparison of endovascular versus transabdominal repair. Ann Surg.1999; 230: 298–308.
11.
ZarinsCKWhiteRAMollFL. The AneuRx stent graft: Four-year results and worldwide experience 2000. J Vasc Surg.2001; 33: S135–145.
12.
DattiloJBBrewsterDCFanCM. Clinical failures of endovascular abdominal aortic aneurysm repair: Incidence, causes, and management. J Vasc Surg.2002; 35: 1137–1144.
13.
ClouseWDBrewsterDCMaroneLK. Durability of aortouniiliac endografting with femorofemoral crossover: 4-year experience in the EVT/Guidant trials. J Vasc Surg.2003; 37: 1142–1149.
14.
HarrisPLVallabhaneniSRDesgrangesP. Incidence and risk factors of late rupture, conversion, and death after endovascular repair of infrarenal aortic aneurysms: The EUROSTAR experience. J Vasc Surg.2000; 32: 739–749.
15.
HölzenbeinTJKretschmerGThurnherS. Midterm durability of abdominal aortic aneurysm endograft repair: A word of caution. J Vasc Surg.2001; 33: S46–54.
16.
ZarinsCKWhiteRAFogartyTJ. Aneurysm rupture after endovascular repair using the AneuRx stent graft. J Vasc Surg.2000; 31: 960–970.
17.
OhkiTVeithFJShawP. Increasing incidence of midterm and long-term complications after endovascular graft repair of abdominal aortic aneurysms: A note of caution based on a 9-year experience. Ann Surg.2001; 234: 323–335.
CarpenterJPBaumRABarkerCF. Impact of exclusion criteria on patient selection for endovascular abdominal aortic aneurysm repair. J Vasc Surg.2001; 34: 1050–1054.
20.
ArkoFRFilisKASeidelSA. How many patients with infrarenal aneurysms are candidates for endovascular repair? The Northern California experience. J Endovasc Ther.2004; 11: 33–40.
21.
MayJWhiteGWaughR. Treatment of complex abdominal aortic aneurysms by a combination of endoluminal and extraluminal aortofemoral grafts. J Vasc Surg.1994; 19: 924–933.
22.
ParodiJCPalmazJCBaroneHD. Transfemoral intraluminal graft implantation for abdominal aortic aneurysms. Ann Vasc Surg.1991; 5: 491–499.
23.
ChuterTAFaruqiRMReillyLM. Aortomonoiliac endovascular grafting combined with femorofemoral bypass: An acceptable compromise or a preferred solution?Semin Vasc Surg.1999; 12: 176–181.
24.
YusufSWWhitakerSCChuterTA. Early results of endovascular aortic aneurysm surgery with aortouniiliac graft, contralateral iliac occlusion, and femorofemoral bypass. J Vasc Surg.1997; 25: 165–172.
RehringTFBrewsterDCCambriaRP. Utility and reliability of endovascular aortomonoiliac with femorofemoral crossover graft for aortoiliac aneurysmal disease. J Vasc Surg.2000; 31: 1135–1141.
27.
MooreWSBrewsterDCBernhardVM. Aortouni-iliac endograft for complex aortoiliac aneurysms compared with tube/bifurcation endografts: Results of the EVT/Guidant trials. J Vasc Surg.2001; 33: S11–20.
28.
PiotrowskiJJPearceWHJonesDN. Aortobifemoral bypass: The operation of choice for unilateral iliac occlusion?J Vasc Surg.1988; 8: 211–218.
29.
LamertonAJNicolaidesANEastcottHH. The femorofemoral graft: Hemodynamic improvement and patency rate. Arch Surg.1985; 120: 1274–1278.
FlaniganDPPrattDGGoodreauJJ. Hemodynamic and angiographic guidelines in selection of patients for femorofemoral bypass. Arch Surg.1978; 113: 1257–1262.
32.
EugeneJGoldstoneJMooreWS. Fifteen year experience with subcutaneous bypass grafts for lower extremity ischemia. Ann Surg.1977; 186: 177–183.
33.
BriefDKBrenerBJ. Extra-anatomic bypasses: Femorofemoral crossover grafts. In: WilsonSEVeithFJHobsonRW, eds. Vascular Surgery: Principles and Practice. New York: McGraw-Hill; 1987: 415–418.
MosleyJGMarstonA. Long term results of 66 femorofemoral bypass grafts: 9-year follow-up. Br J Surg.1983; 70: 631–634.
36.
MainiBSMannickJA. Effect of arterial reconstruction on limb salvage: A ten-year appraisal. Arch Surg.1978; 113: 1297–1304.
37.
CriadoEBurnhamSJTinsleyEA. Femorofemoral bypass grafts: Analysis of patency and factors influencing long term outcome. J Vasc Surg.1993; 18: 495–505.
38.
MingoliASapienzaPFeldhausRJ. Femorofemoral bypass grafts: Factors influencing long term patency rate and outcome. Surgery. 2001; 129: 451–458.
39.
KomoriKOkadomeKFunahashiS. Correlation of long-term results of extra-anatomic bypass and flow wave-form analysis. Eur J Vasc Surg.1993; 7: 479–482.
40.
Thompson-FawcettMMoonMHandsL. The significance of donor leg distal runoff in femorofemoral bypass grafting. Aust NZ J Surg.1998; 68: 493–497.
41.
FarberMAHollierLHEubanksR. Femorofemoral bypass: A profile of graft failure. South Med J.1990; 83: 1437–1443.
42.
SchneiderJRBessoSRWalshDB. Femorofemoral versus aortobifemoral bypass: Outcome and hemodynamic results. J Vasc Surg.1994; 19: 43–57.
43.
SelfSBRichardsonJDKlamerTW. Utility of femorofemoral bypass. Comparison of results with indications for operations. Am Surg.1991; 57: 602–606.
44.
HinchliffeRJAlricPWenhamPW. Durability of femorofemoral bypass grafting after aortouniiliac endovascular aneurysm repair. J Vasc Surg.2003; 38: 498–503.
45.
LipsitzECOhkiTVeithFJ. Patency rates of femorofemoral bypasses associated with endovascular aneurysm repair surpass those performed for occlusive disease. J Endovasc Ther.2003; 10: 1061–1065.
46.
YilmazLPAbrahamCZReillyLM. Is cross-femoral bypass grafting a disadvantage of aortomonoiliac endovascular aortic aneurysm repair?J Vasc Surg.2003; 38: 753–757.
47.
WalkerSRBraithwaiteBTennantWG. Early complications of femorofemoral crossover bypass grafts after aorta uni-iliac endovascular repair of abdominal aortic aneurysms. J Vasc Surg.1998; 28: 647–650.
